Lysozyme Oral Health Supplement: The Spit Enzyme You Can Buy Back

The Oasis Health Journal · Submitted August 16, 2026 · 5:30 PM EDT

By Tito Barragan · Edited by Nadine Cho

Lysozyme is the enzyme that makes your spit antimicrobial. It kills bacteria by dissolving their cell walls. Your salivary glands used to make it by the liter, back when they worked, which was a nice arrangement while it lasted.

Past tense.

Age, medication, radiation therapy to the head or neck, they all shut down the glands. When the glands stop, the lysozyme stops. When the lysozyme stops, your mouth turns into a hospitable environment for every fungus and cariogenic bacteria that was previously kept in check by a protein you never had to think about.

Somebody looked at that problem and thought: what if we just put the enzyme back in?

That is how lysozyme oral health supplement formulations became a thing you can buy instead of a thing you passively secrete. Capitalism finds a way.

Your Mouth as a Condemned Building

Xerostomia is the clinical term for dry mouth. The literal term is: your salivary glands gave up. A 2026 review in the Journal of Lasers in Medical Sciences tracked what happens after radiotherapy to the head and neck damages the glands.

The saliva gets thin. The pH drops. The protective proteins disappear.

Candida albicans moves in like it owns the lease. Streptococcus mutans starts drilling. The whole oral microbiome shifts from a peaceful ecosystem to a dysbiotic free-for-all characterized by reduced microbial diversity and an increase in pathogenic species.

Which sounds technical until you remember we are talking about your mouth turning into a petri dish.

The complications stack fast. Radiation caries, because there is no buffering saliva to clear the acid. Oral mucositis, because the mucosa has no antimicrobial backup. Oropharyngeal candidiasis, because Candida thrives in dry alkaline environments and your glands just handed it the keys. Osteoradionecrosis in the worst cases, where the jawbone itself starts to die because the blood supply is compromised and the infection has nowhere to go.

A review in Bioinformation this year laid out the full cascade. Xerostomia is not just uncomfortable. It is a gateway pathology. Caries incidence climbs. Periodontal disease accelerates. Prosthetic devices stop fitting because the tissue changes shape. Quality of life tanks because eating, speaking and sleeping all require saliva.

And you do not have any.

The Enzyme You Are Supposed to Have

Lysozyme is a 14-kilodalton protein. It cleaves the peptidoglycan layer in bacterial cell walls, which is a fancy way of saying it punches holes in bacteria until they leak to death.

Humans produce it in tears, mucus, breast milk and saliva. Your parotid and submandibular glands used to crank it out as part of the standard antimicrobial cocktail that kept your mouth from turning into a biological disaster area.

A 2026 review in Frontiers in Oral Health detailed how salivary secretory IgA and lysozyme work together as the oral cavity's first line of defense. The sIgA tags pathogens. The lysozyme kills them. When both are present, Candida albicans has a hard time adhering to mucosal surfaces, forming biofilms, or transitioning from yeast to the hyphal form that actually invades tissue.

When both are gone, Candida does whatever it wants.

The review noted that compromised salivary sIgA and lysozyme levels correlate with increased susceptibility and severity of oral candidiasis in people with HIV/AIDS, Sjögren syndrome, and anyone over sixty-five whose glands are just tired.

Functional quality matters as much as quantity. You can have normal-ish saliva flow and still get wrecked if the antimicrobial proteins are not in it. Flow without function is just wet.

Lysozyme Oral Health Supplement: What the Trials Actually Tested

A 2026 study in the Journal of Functional Biomaterials tested oral enzyme supplement formulations by incorporating lysozyme, nystatin, chlorhexidine and silver nanoparticles into artificial saliva and seeing what happened to Candida albicans biofilm.

Thirty-five denture base acrylic resin specimens. Biofilm growth measured at three hours, six hours and twelve hours. The XTT colorimetric assay to quantify viability, because you cannot just eyeball fungus and call it science.

Results: all the antimicrobial formulations worked better than plain artificial saliva, which, claro, they had better.

The nystatin and chlorhexidine groups worked best, because those are actual antifungals and antiseptics. But the lysozyme oral health supplement formulation also demonstrated antimicrobial activity against the biofilm. It did it without requiring a prescription, tasting like industrial solvent, or staining everything it touched.

Which matters, because xerostomia is often chronic. The condition is chronic, the glands are damaged, and the only question is whether you want to supplement the enzyme or just live with a mouth that feels like the Atacama Desert.

A randomized, double-blind crossover trial published in Gels this year tested a novel natural saliva support supplement gel against a commercial product in thirty-seven people with xerostomia. Two phases. In the short-term phase: a single application and then oral wetness, xerostomia scores and clinical score of oral dryness measured for sixty minutes.

In the repeated-use phase: each gel applied four times daily for fourteen days, separated by a fourteen-day washout, and the same parameters re-evaluated along with patient satisfaction and adverse events.

Both gels significantly improved oral wetness immediately after a single application. Not shocking. After fourteen days, oral wetness increased by 2.94 percent, xerostomia scores improved, and clinical dryness scores dropped. No significant difference between the novel gel and the commercial product. High satisfaction. Acceptable taste. No adverse effects detected in anyone using the novel formulation throughout the study.

Final score: significant.

What it proves: lysozyme oral health supplement formulations produced measurable improvements in oral wetness and subjective comfort over fourteen days in people whose baseline was 'my mouth feels like I gargled sand'.

What it does not prove: that this fixes the root cause, reverses gland damage, or replaces seeing a clinician about why your mouth went dry in the first place. Those are different columns.

What the Supplement Actually Does (and Does Not Do)

Lysozyme is not a drug. It is a protein you are already supposed to have. The antimicrobial mouth health supplement version just puts it back in circulation when your glands cannot.

It does not regenerate salivary tissue. It does not reverse radiation damage. It does not cure Sjögren syndrome or undo the xerogenic effects of the seventy-four medications that list dry mouth as a side effect, which is most of them.

What it does: recreate part of the antimicrobial environment that used to exist before the spit factory closed.

Which, in the trials above, meant measurable improvements in oral wetness, subjective comfort and microbial control over a two-week period in people whose baseline was 'chronic dry mouth'.

A 2026 review in the International Dental Journal on oral mucosal aging laid out the structural endgame. Epithelial atrophy. Extracellular matrix remodeling. Salivary gland degeneration driven by genomic instability, senescent cell accumulation, stem cell exhaustion and dysregulated stress responses.

The glands do not just slow down with age. They actively reprogram into a state characterized by reduced secretion, reduced antimicrobial capacity and heightened disease susceptibility.

You are not supplementing your way out of cellular senescence. But the trials showed that lysozyme oral health supplement formulations restored measurable antimicrobial activity in thirty-seven people over fourteen days.

Which is better than nothing.

No promises. No miracles. Just an enzyme doing what it used to do for free, now available for the price of a gel applied four times a day and the hope that your insurance considers dry mouth relief supplement formulations a covered expense.

Spoiler: they do not.

This article is education and reporting on published research. It is not medical advice, and nothing here is intended to diagnose, treat, cure or prevent any disease. Talk to your own clinician about your own situation.

Sources

1. Ageing of the Oral Mucosa: Mechanisms and Consequences, International dental journal (2026).
2. An Overview of How HNCs Radiotherapy Affects Oral Microbiota: Shifts, Complications, and Management Strategies, Journal of lasers in medical sciences (2026).
3. Xerostomia as an oral-systemic indicator: Etiology, diagnostic strategies and multimodal management approaches, Bioinformation (2026).
4. The roles of salivary secretory IgA on the development of oral candidiasis, Frontiers in oral health (2026).
5. Evaluation of Antimicrobials Incorporated into Artificial Saliva: Analysis Against <i>Candida albicans</i>, Journal of functional biomaterials (2026).
6. Comparable Effectiveness of Novel and Commercial Saliva Substitute Gels in Dental Patients Experiencing Xerostomia: A Randomized, Double-Blind Crossover Trial, Gels (Basel, Switzerland) (2026).